Mechanisms and Genetics of Antipsychotic-Associated Weight Gain
Antipsychotic medications, which comprise one of the most widely prescribed medication classes, have proven effective in many psychiatric conditions. However, these agents can also be associated with obesity and other metabolic abnormalities, the mechanisms of which have been partially elucidated. W...
Gespeichert in:
Veröffentlicht in: | Clinical pharmacology and therapeutics 2011-07, Vol.90 (1), p.179-183 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Antipsychotic medications, which comprise one of the most widely prescribed medication classes, have proven effective in many psychiatric conditions. However, these agents can also be associated with obesity and other metabolic abnormalities, the mechanisms of which have been partially elucidated. We review here the current state of knowledge of the effects of these medications on weight and appetite, as well as genetic markers that may help predict weight gain and prevent the undesirable cardiometabolic effects of these agents.
Clinical Pharmacology & Therapeutics (2011) 90 1, 179–183. doi:10.1038/clpt.2011.97 |
---|---|
ISSN: | 0009-9236 1532-6535 |
DOI: | 10.1038/clpt.2011.97 |